毕得医药 (688073.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(毕得医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度每股收益(元) -----1.001.00
 单季度销售毛利率(%) 44.0040.0039.0039.0039.0038.0044.00
 单季度销售净利率(%) 11.0010.0010.00-1.0010.0017.0015.00
 单季度净资产收益率ROE(%) 2.001.001.00-1.002.002.00
 单季度总资产净利率ROA(%) 1.001.001.00-1.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 279,170,580.00269,537,332.00262,669,978.00286,851,826.00282,381,419.00270,169,416.00252,455,900.00
 单季度营业总成本(元) 240,614,339.00230,921,484.00225,411,993.00286,013,070.00244,699,215.00206,432,704.00203,401,461.00
 单季度营业收入(元) 279,170,580.00269,537,332.00262,669,978.00286,851,826.00282,381,419.00270,169,416.00252,455,900.00
 单季度营业利润(元) 38,212,771.0032,886,958.0031,187,836.00-5,735,973.0034,357,387.0054,362,815.0043,644,938.00
 单季度利润总额(元) 38,137,392.0032,943,937.0031,310,230.00-5,933,949.0034,487,983.0054,171,883.0043,270,854.00
 单季度净利润(元) 32,014,828.0025,764,122.0026,074,943.00-4,201,331.0029,064,602.0046,654,787.0036,928,240.00
 单季度归属母公司股东的净利润(元) 32,014,828.0025,764,122.0026,074,943.00-3,826,898.0029,588,307.0046,882,139.0036,928,240.00
 单季度经营活动产生的现金流量(元) 10,872,526.0041,509,930.0048,167,499.0065,485,522.00-77,636,834.00-23,778,672.00-21,457,616.00
 单季度投资活动产生的现金流量(元) -83,063,851.00-265,739,788.00-945,983.0032,684,245.00-11,612,522.00-42,934,726.00-7,002,749.00
 单季度筹资活动产生的现金流量(元) 5,147,052.00-103,637,620.00-37,126,745.00-9,915,931.00-9,968,061.00-115,376,402.00-3,045,408.00
 单季度现金及现金等价物净增加(元) -68,282,160.00-327,047,085.009,172,630.0081,277,116.00-101,742,353.00-178,255,635.00-31,671,755.00

前瞻产业研究院